Medicenna Therapeutics Corp. Cash And Cash Equivalents
Medicenna Therapeutics Corp. (MDNAF) had Cash And Cash Equivalents of CAD 33.60 million as of 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:CashAndCashEquivalents · last filed 2023-06-27
- 2023-03-31: Cash And Cash Equivalents 33.60M CAD.
- 2022-12-31: Cash And Cash Equivalents 20.54M CAD.
- 2022-03-31: Cash And Cash Equivalents 20.54M CAD.
- 2021-12-31: Cash And Cash Equivalents 30.38M CAD.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2023-03-31 | 33.60M CAD 20-F · filed 2023-06-27 |
| 2022-12-31 | 20.54M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 20.54M CAD 20-F · filed 2023-06-27 |
| 2021-12-31 | 30.38M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 30.38M CAD 20-F · filed 2023-06-27 |
| 2020-12-31 | 22.70M CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | 22.70M CAD 20-F · filed 2022-06-22 |
| 2019-03-31 | 2.37M CAD 20-F · filed 2022-06-22 |